Knight Therapeutics Inc (FRA:04K)
€ 3.42 -0.36 (-9.52%) Market Cap: 354.19 Mil Enterprise Value: 277.97 Mil PE Ratio: 0 PB Ratio: 0.67 GF Score: 88/100

Knight Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 25, 2020 / 02:00PM GMT
Release Date Price: €4.62 (-1.70%)
Operator

Hello, and welcome to the Annual Meeting of Stockholders of Knight Therapeutics. Please note, today's meeting is being recorded. (Operator Instructions)

It is now my pleasure to turn the meeting over to Jonathan Goodman, CEO of Knight Therapeutics. The floor is yours.

Jonathan Ross Goodman
Knight Therapeutics Inc. - Founder, CEO & Director

Good morning. Welcome to Knight Therapeutics' Annual Meeting of Shareholders. We have chosen to hold the meeting via live audio webcast rather than in person as a result of the recent global pandemic due to COVID-19 and to ensure everyone's safety.

My name is Jonathan Goodman, CEO of Knight Therapeutics. And exceptionally, I will chair today's meeting. Also with me on this call is Samira Sakhia, our President; and Bryan Kujawski, our External Counsel. Samira will act as secretary of today's meeting. Bertrand Gely and [Ivan Karekezi] of AST Trust Company will be acting as scrutineers for this meeting.

Our agenda today is straightforward. First, we will conduct the formal part of the meeting.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot